About STAGA complex 65 subunit gamma
STAGA complex 65 subunit gamma (SUPT7L) is a protein
from Homo sapiens identified by UniProt accession
O94864, 414 residues long.
MolForge cross-references it against 0 known binders and
79 disease associations.
Target properties
| Protein name | STAGA complex 65 subunit gamma |
| UniProt accession | O94864 |
| Gene | SUPT7L |
| Organism | Homo sapiens |
| Length | 414 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (79)
Diseases linked to this target (Open Targets).
- breast adenocarcinoma · score 0.22
- hemoglobin measurement · score 0.17
- systolic blood pressure · score 0.11
- erythrocyte count · score 0.08
- uncombable hair syndrome · score 0.07
- very low density lipoprotein cholesterol measurement · score 0.06
- chylomicron measurement · score 0.06
- phospholipid measurement · score 0.06
- alcohol consumption measurement · score 0.05
- Woolly hair · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O94864-F1 | alphafold | PREDICTED | 64.96 | — |
Amino-acid sequence (414 residues)
MNLQRYWGEI PISSSQTNRS SFDLLPREFR LVEVHDPPLH QPSANKPKPP TMLDIPSEPC SLTIHTIQLI QHNRRLRNLI ATAQAQNQQQ TEGVKTEESE PLPSCPGSPP LPDDLLPLDC KNPNAPFQIR HSDPESDFYR GKGEPVTELS WHSCRQLLYQ AVATILAHAG FDCANESVLE TLTDVAHEYC LKFTKLLRFA VDREARLGQT PFPDVMEQVF HEVGIGSVLS LQKFWQHRIK DYHSYMLQIS KQLSEEYERI VNPEKATEDA KPVKIKEEPV SDITFPVSEE LEADLASGDQ SLPMGVLGAQ SERFPSNLEV EASPQASSAE VNASPLWNLA HVKMEPQESE EGNVSGHGVL GSDVFEEPMS GMSEAGIPQS PDDSDSSYGS HSTDSLMGSS PVFNQRCKKR MRKI
Explore STAGA complex 65 subunit gamma with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets